Zydis® ODT Provides Better Treatments

Summary: New study shows superior patient compliance with oral fast dissolve delivery; Specifically with how Zelapar (Selegiline anti-Parkinson’s compound) had a positive impact on therapeutic profile vs. Selegiline in traditional tablets. Discover how Zydis® fast-dissolve delivery improved compliance, enhanced the drug product profile, and grew market share.

Click here to download the case study.